FDA Published Draft Guidance on Development of CAR-T Cell Products Post author:PacConAdmin Post published:March 15, 2022 Post category:Drug Industry Daily The FDA has posted draft guidance for sponsors developing CAR-T cell products. Source: Drug Industry Daily You Might Also Like Alleging Monopoly, Pension Funds Sue BMS and Generics Firms Over Pay-to-Play Deals November 23, 2022 FDA Ordered to Create a New Regulatory Task Force February 24, 2017 Federal Lawsuit Alleges FDA Revealed Trade Secrets to Generics Manufacturers May 3, 2023